EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieValidierungsstudie

Validation of Wound, Ischemia, and Foot Infection Classification in Infrapopliteal Arterial Disease Undergoing Endovascular Therapy

Julong Guo, Jianming Guo, Xixiang Gao, Zibo Feng, Ziheng Wu, Chunshui He, Qiang Li, Xin Fang, Hongfei Sang, Zhenyu Shi, Weihao Shi, Hui Zhuang und 4 weitere

JACC: Cardiovascular Interventions · 2026-04 · 19 (8) · 1004-1017

DOI: 10.1016/j.jcin.2026.01.311 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2026-04. Verfasst von Julong Guo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Xuanwu Hospital Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Endovascular Procedures, Peripheral Arterial Disease, Ischemia, Decision Support Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The Wound, Ischemia, and Foot Infection (WIfI) classification system was proposed to improve risk stratification and prognostic prediction in chronic limb-threatening ischemia patients. OBJECTIVES: The aim of this prospective, multicenter observational study was to evaluate the prognostic value of the WIfI classification in patients with infrapopliteal arterial occlusive disease undergoing endovascular therapy. METHODS: Patients from 10 Chinese centers were enrolled. The primary outcome was 12-month freedom from major adverse events (MAE), which was a composite of major amputation, all-cause death, and clinically driven target limb reintervention. Secondary outcomes included amputation-free survival and the composite components of the primary outcome. RESULTS: This study involved 944 patients (975 limbs). Cox regression analysis identified WIfI stage as an independent predictor of MAE (HR: 1.23; 95% CI: 1.06-1.43; P = 0.007). Additionally, WIfI stage was independently associated with combined major amputation or all-cause death (HR: 1.41; 95% CI: 1.18-1.69; P < 0.001) and with all-cause death alone (HR: 1.38; 95% CI: 1.12-1.70; P = 0.002). WIfI stage 4 carried a consistently higher risk for these 3 endpoints compared with stages 1 to 3. Although WIfI stage was independently linked to major amputation, pairwise comparisons did not show significant differences among stages. No independent association was observed between WIfI stage and clinically driven target lesion reintervention. CONCLUSIONS: Although the WIfI classification system shows predictive ability for MAE, amputation-free survival, major amputation, and all-cause death, the prognostic differences are driven primarily by stage 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endovascular ProceduresPeripheral Arterial DiseaseIschemiaDecision Support TechniquesWound InfectionPopliteal ArteryHumansRisk FactorsAmputation, SurgicalPredictive Value of TestsTime FactorsFemaleLimb SalvageProspective StudiesTreatment OutcomeProgression-Free SurvivalMaleRisk AssessmentAgedChinaReproducibility of ResultsMiddle AgedAged, 80 and overChronic Disease

Stichwörter der Autor:innen

WIfI classification systemchronic limb-threatening ischemiaendovascular therapyinfrapopliteal arterial occlusive disease

Autor:innen und Institutionen

  • Department of Vascular Surgery, Xuanwu Hospital Capital Medical University, Beijing, China.
  • Department of Vascular Surgery, Liyuan Hospital Affiliated Tongji Medical Collage of Huazhong University of Science and Technology, Wuhan, China.
  • Department of Vascular Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Vascular Surgery, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Vascular Surgery, The Affiliated Qingdao Hiser Hospital of Qingdao University, Qingdao, China.
  • Department of Vascular Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.

Förderung

  • Ministry of Science and Technology of the People&apos;s Republic of China

Zitieren

APA

Guo, J., Guo, J., Gao, X., Feng, Z., Wu, Z., He, C., Li, Q., Fang, X., Sang, H., Shi, Z., Shi, W., Zhuang, H., Zhang, W., Tong, Z., Ye, M., & Guo, L. (2026). Validation of Wound, Ischemia, and Foot Infection Classification in Infrapopliteal Arterial Disease Undergoing Endovascular Therapy. JACC: Cardiovascular Interventions, 19(8), 1004-1017. https://doi.org/10.1016/j.jcin.2026.01.311

Vancouver

Guo J, Guo J, Gao X, Feng Z, Wu Z, He C, et al. Validation of Wound, Ischemia, and Foot Infection Classification in Infrapopliteal Arterial Disease Undergoing Endovascular Therapy. JACC: Cardiovascular Interventions. 2026;19(8):1004-1017. doi:10.1016/j.jcin.2026.01.311

BibTeX
@article{Guo2026,
  author = {Guo, Julong and Guo, Jianming and Gao, Xixiang and Feng, Zibo and Wu, Ziheng and He, Chunshui and Li, Qiang and Fang, Xin and Sang, Hongfei and Shi, Zhenyu and Shi, Weihao and Zhuang, Hui and Zhang, Wei and Tong, Zhu and Ye, Meng and Guo, Lianrui},
  title = {Validation of Wound, Ischemia, and Foot Infection Classification in Infrapopliteal Arterial Disease Undergoing Endovascular Therapy},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {8},
  pages = {1004--1017},
  doi = {10.1016/j.jcin.2026.01.311}
}
Kostenlos starten →